|Rotavirus NSP1 inhibits NFkappaB activation by inducing proteasome-dependent degradation of beta-TrCP: a novel mechanism of IFN antagonism.|
|Jump to Full Text|
|PMID: 19180189 Owner: NLM Status: MEDLINE|
|Mechanisms by which viruses counter innate host defense responses generally involve inhibition of one or more components of the interferon (IFN) system. Multiple steps in the induction and amplification of IFN signaling are targeted for inhibition by viral proteins, and many of the IFN antagonists have direct or indirect effects on activation of latent cytoplasmic transcription factors. Rotavirus nonstructural protein NSP1 blocks transcription of type I IFNalpha/beta by inducing proteasome-dependent degradation of IFN-regulatory factors 3 (IRF3), IRF5, and IRF7. In this study, we show that rotavirus NSP1 also inhibits activation of NFkappaB and does so by a novel mechanism. Proteasome-mediated degradation of inhibitor of kappaB (IkappaBalpha) is required for NFkappaB activation. Phosphorylated IkappaBalpha is a substrate for polyubiquitination by a multisubunit E3 ubiquitin ligase complex, Skp1/Cul1/F-box, in which the F-box substrate recognition protein is beta-transducin repeat containing protein (beta-TrCP). The data presented show that phosphorylated IkappaBalpha is stable in rotavirus-infected cells because infection induces proteasome-dependent degradation of beta-TrCP. NSP1 expressed in isolation in transiently transfected cells is sufficient to induce this effect. Targeted degradation of an F-box protein of an E3 ligase complex with a prominent role in modulation of innate immune signaling and cell proliferation pathways is a unique mechanism of IFN antagonism and defines a second strategy of immune evasion used by rotaviruses.|
|Joel W Graff; Khalil Ettayebi; Michele E Hardy|
Related Documents :
|11956289 - Link between organ-specific antigen processing by 20s proteasomes and cd8(+) t cell-med...
12615719 - Cytokine activation of phosphoinositide 3-kinase sensitizes hematopoietic cells to cisp...
18266129 - Phase-contrast microscopy studies of early cisplatin-induced morphological changes of m...
19034669 - Calpain and proteasomal regulation of antiretroviral zinc finger protein otk18 in human...
17291459 - Effects of hydroxyl radical scavenging on cisplatin-induced p53 activation, tubular cel...
16678019 - Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-...
2080759 - Putative role of epithelial derived factors in airway smooth muscle reactivity.
12213579 - Prospects for targeting the bcl-2 family of proteins to develop novel cytotoxic drugs.
21621649 - The uptake of plga micro or nanoparticles by macrophages provokes distinct in vitro inf...
|Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. Date: 2009-01-30|
|Title: PLoS pathogens Volume: 5 ISSN: 1553-7374 ISO Abbreviation: PLoS Pathog. Publication Date: 2009 Jan|
|Created Date: 2009-01-30 Completed Date: 2009-04-17 Revised Date: 2009-11-18|
Medline Journal Info:
|Nlm Unique ID: 101238921 Medline TA: PLoS Pathog Country: United States|
|Languages: eng Pagination: e1000280 Citation Subset: IM|
|Veterinary Molecular Biology, Montana State University, Bozeman, Montana, United States of America.|
|APA/MLA Format Download EndNote Download BibTex|
Gene Expression Regulation, Viral
I-kappa B Proteins / metabolism
Interferon Regulatory Factor-3 / metabolism
Interferon-beta / metabolism
NF-kappa B / metabolism
Proteasome Endopeptidase Complex / metabolism*
Rotavirus / genetics, metabolism*
Rotavirus Infections / metabolism*, virology
Transcription Factor RelA / metabolism
Viral Nonstructural Proteins / genetics, metabolism*
beta-Transducin Repeat-Containing Proteins / metabolism*
|P20 RR020185/RR/NCRR NIH HHS|
|0/I-kappa B Proteins; 0/Interferon Regulatory Factor-3; 0/NF-kappa B; 0/NSP1 protein, Rotavirus; 0/Transcription Factor RelA; 0/Viral Nonstructural Proteins; 0/beta-Transducin Repeat-Containing Proteins; 139874-52-5/NF-kappaB inhibitor alpha; 77238-31-4/Interferon-beta; EC 188.8.131.52/Proteasome Endopeptidase Complex|
Journal ID (nlm-ta): PLoS Pathog
Journal ID (publisher-id): plos
Journal ID (pmc): plospath
Publisher: Public Library of Science, San Francisco, USA
Graff et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received Day: 10 Month: 7 Year: 2008
Accepted Day: 26 Month: 12 Year: 2008
collection publication date: Month: 1 Year: 2009
Print publication date: Month: 1 Year: 2009
Electronic publication date: Day: 30 Month: 1 Year: 2009
Volume: 5 Issue: 1
E-location ID: e1000280
PubMed Id: 19180189
Publisher Id: 08-PLPA-RA-0740R3
|Rotavirus NSP1 Inhibits NF?B Activation by Inducing Proteasome-Dependent Degradation of ?-TrCP: A Novel Mechanism of IFN Antagonism Alternate Title:NSP1 Targets ?-TrCP for Proteasome Degradation|
|Joel W. Graffaff1|
|Michele E. Hardyaff1*|
|Veterinary Molecular Biology, Montana State University, Bozeman, Montana, United States of America
|North Carolina State University, United States of America
|Correspondence: * E-mail: email@example.com
Contributed by footnote: Conceived and designed the experiments: JWG KE MEH. Performed the experiments: JWG KE. Analyzed the data: JWG KE MEH. Wrote the paper: JWG KE MEH.
Research into mechanisms by which viruses evade host defense has received increased attention in the past several years because of the potential to develop attenuated vaccines based on viruses with weakened evasion strategies, or antiviral therapies that target specific immune system antagonists. Most, if not all, viruses encode proteins that interfere with signal transduction pathways involved in induction or amplification of the immune response, particularly the innate response driven by type I interferon (IFN?/?) . IFN?/? are cytokines that stimulate expression of genes that interfere directly with steps in the virus replication cycle, and genes whose protein products modulate and recruit the adaptive immune response. The antiviral state that is established by the IFN system serves to restrict virus replication and spread while effectors of the slower adaptive immune response are recruited to the site of infection.
The mechanisms of IFN?/? induction are relatively well understood  although proteins involved in this pathway continue to be identified ,,. Induction of IFN? transcription occurs through assembly of transcription factors interferon regulatory factor 3 (IRF3), NF?B, and ATF2/c-Jun on the positive regulatory domain enhancer element of the IFN? promoter, and the interferon stimulated response element (ISRE) in promoters of a subset IFN-stimulated genes (ISG) ,,. Secreted IFN? binds to cell surface type I IFN receptors and activates the JAK/STAT pathway, resulting in formation of IFN-stimulated gene factor-3 (ISGF3). ISGF3 is a heterotrimeric complex consisting of STAT1, STAT2, and IRF9. ISGF3 translocates to the nucleus and induces transcription of IFN? and numerous ISGs, thus amplifying the response through a positive feedback mechanism. Each of the steps in the IFN signaling pathway has been reported as targets for viral IFN antagonists. A recent summary of mechanisms viruses use to block the IFN response clearly illustrates that some viral proteins target more than one step in the pathway (e.g. influenza virus NS1) and some viruses encode more than one IFN antagonist (e.g. paramyxovirus V, C, and N proteins), exemplifying the importance of IFN signaling to host defense ,.
Signal transduction pathways that activate IRF3 and NF?B have been well studied in the context of the virus-induced IFN response. Upon virus detection, IRF3 is phosphorylated at its C terminus by kinases TBK1 or IKK? , dimerizes and then translocates to the nucleus to assemble at the IFN? promoter and select ISRE-containing promoters in cooperation with transcription co-activators . IRF3 activation is required for IFN? transcription, and the number of reports of viruses that interfere directly with the function of IRF3, or the steps preceding its activation has grown significantly in recent years . For example, the hepatitis C virus NS3-4A protease complex cleaves TLR3 adaptor protein TRIF, blocks RIG-I signaling and cleaves adaptor protein IPS (also known as MAVS/Cardif/VISA) to release it from the mitochondrial membrane, consequently blocking IRF3 activation ,. One of the more recently defined viral IFN antagonists is rotavirus nonstructural protein NSP1. NSP1 targets IRF3, IRF5, and IRF7 for proteasome-dependent degradation early post-infection ,,. By targeting IRFs for degradation, NSP1 enhances rotavirus cell-to-cell spread in vitro.
NF?B is required for induction of IFN? transcription, although exceptions to the requirement for NF?B under select experimental conditions have been reported ,. NF?B is activated by numerous stimuli, and in addition to regulating gene expression associated with innate and adaptive immune responses, functions in signaling pathways that control cell division and apoptosis . NF?B subunits are held inactive in the cytoplasm by association with inhibitors of ?B (I?B). Phosphorylation of I?B by I?B kinases (IKK?/?) results in its rapid ubiquitination by the E3 ligase Skp1/Cul1/F-box complex, SCF?-TrcP, and subsequent degradation by the 26S proteasome . I?B degradation releases the p50/relA (p65) heterodimer, which translocates to the nucleus for promoter binding and transcription of NF?B target genes. Multiple steps in the NF?B pathway are targets for viral IFN antagonists, some of which are common to the IRF3 activation pathway .
Rotaviruses cause severe gastroenteritis in infants and young children, and in newborns of most mammalian species . The rotavirus genome consists of 11 segments of dsRNA encoding six structural proteins and six nonstructural proteins. Nonstructural protein NSP1 is the least conserved protein among different strains; however, a zinc-binding domain comprised of a specific pattern of cysteine and histidine residues near the amino terminus is invariant . Results from our laboratory and others have shown that NSP1 from several different rotavirus strains targets IRF3 for proteasome degradation early post-infection. Expression of NSP1 in the absence of infection directs IRF3 degradation, indicating it is the sole viral protein that mediates this effect. NSP1 of simian rotavirus also directs proteasome-mediated degradation of IRF5 and IRF7 . Investigation into the properties of NSP1 responsible for IRF3 degradation showed the conserved zinc finger domain is required for this activity .
Modification of eukaryotic proteins with ubiquitin (Ub) prior to proteasome degradation requires an E1 activating enzyme, E2 conjugating enzyme, and an E3 ligase that transfers Ub from E2 to the target substrate . E3 ligases fall into two major classes of proteins that contain either a catalytic HECT domain or a RING domain. Typical RING domains consist of cysteine and histidine residues spaced in a C3HC4 pattern that coordinately bind two zinc ions , yet evidence is accumulating that variations of the C3HC4 pattern exist in the RING superfamily . Viral proteins with cysteine-histidine rich zinc binding domains have demonstrated E3 ligase activity, and many of the cellular targets of viral E3s are associated with regulation of immune responses to infection . The pattern of cysteine and histidine residues in the zinc finger motif of NSP1 is similar, but not identical, to RING finger domains in cellular E3 ubiquitin ligases. Thus we proposed that NSP1 contained a variant RING domain signature and functioned as a viral E3 ubiquitin ligase that targets proteins with roles in the IFN signaling pathway as substrates for proteasome degradation .
We recently reported that IRF3 was activated and stable in cells infected with porcine rotavirus strain OSU . Therefore, we sought to determine if an alternative mechanism to block induction of IFN? was encoded in the rotavirus genome. The studies reported herein revealed that NF?B activation was blocked in OSU infected cells due in part to stabilization of phosphorylated I?B?. Dissection of the steps involved in I?B? degradation revealed that the substrate recognition protein, ?-transducin repeat containing protein (?-TrCP), of the cellular E3 ubiquitin ligase complex SCF?-TrcP is targeted for proteasome degradation by NSP1. The SCF?-TrCP E3 ligase is responsible for ubiquitination of I?B? ,, thus providing an explanation for I?B? stabilization and the lack of NF?B activation in infected cells. Targeted degradation of a cellular F-box protein required for E3 ligase substrate recognition is a novel IFN evasion strategy, and defines a second mechanism of interference with the innate immune response encoded in the rotavirus genome.
IRF3 is phosphorylated in OSU infected MA104 cells, indicating that the virus is detected and signaling pathways leading to IRF3 phosphorylation are intact. Once phosphorylated, IRF3 dimerizes and translocates to the nucleus to assemble with transcription co-activators on the IFNB promoter as well as ISRE-containing promoters. To test whether these latter steps in the activation pathway were affected by OSU infection, the cellular distribution of IRF3 was analyzed by IF microscopy (Figure 1A). Bovine rotavirus strains A5-16 and NCDV also were analyzed in these experiments for comparison with OSU because the behavior of these strains with respect to IRF3 activation has been described. A5-16 encodes a truncated NSP1 , and IRF3 is phosphorylated and stable in A5-16 infected cells . NCDV encodes an NSP1 that binds to and targets IRF3 for proteasome degradation ,. The microscopy revealed that IRF3 was diffusely distributed in the cytoplasm in mock infected cells. In A5-16 infected cells, IRF3 accumulated in the nucleus as expected. IRF3 also accumulated in the nucleus of OSU infected cells, indicating nuclear translocation is not inhibited in MA104 cells infected with this rotavirus strain. IRF3 was not detected at all in NCDV infected cells, consistent with its degradation early post-infection.
The presence of nuclear IRF3 led us to test whether IFN? mRNA was synthesized in cells infected with each of the three strains. IFN? was strongly induced in A5-16 infected cells as expected, but not in NCDV or OSU infected cells (Figure 1B). The lack of IFN? mRNA in NCDV infected cells can be explained by degradation of IRF3, but nuclear IRF3 in OSU infected cells suggested an alternative mechanism was used by this virus to block IFN? transcription.
NSP1 encoded by rotavirus strains analyzed thus far directs proteasome-mediated degradation of IRF3 when expressed in the absence of infection. To determine whether NSP1 encoded by OSU played a role in inhibiting IFN? transcription, 293-TLR3 cells  were transfected with a plasmid encoding OSU NSP1 (pO-NSP1) or NCDV NSP1 (pN-NSP1), and a reporter plasmid encoding firefly luciferase under control of the IFN? promoter. Cells then were treated with polyI:C to induce reporter gene expression. Expression of OSU NSP1 inhibited polyI:C-induced luciferase expression by ?20-fold compared to cells transfected with empty vector (Figure 1C). Reporter expression in cells expressing NCDV NSP1 was inhibited ?30-fold; a substantial portion of this reduction can be attributed to the lack of IRF3. We note that the basal levels of luciferase expression induced by each plasmid in the absence of polyI:C treatment showed a similar pattern; that is, luciferase expression was inhibited when cells expressed NSP1, and the magnitude of the reduction was most prominent for OSU NSP1. These results demonstrate that OSU NSP1 inhibits IFN? promoter-driven gene expression in the absence of infection, and without an obvious mechanism to interfere with the function of IRF3.
Recent studies defined a hyperphosphorylated form of IRF3 that translocates to the nucleus but is degraded, and therefore is transcriptionally inactive . The transcriptional activity of nuclear IRF3 was examined by RT-PCR of IP-10, ISG56, and IFN? mRNA. IRF3-regulated genes IP-10 and ISG56 have different transcription factor requirements for expression. While IFN? and IP-10 generally require both IRF3 and NF?B with noted exceptions ,, IRF3 is sufficient to induce ISG56 . IP-10 and ISG56 mRNA were analyzed by RT-PCR to further dissect the activity of transcription factors required for expression of these genes in infected cells. A5-16 induced transcription of both IP-10 and ISG56, but neither were induced in NCDV infected cells (Figure 1B). In contrast, OSU infection induced ISG56, but not IP-10. The fact that ISG56 was induced in OSU infected cells confirmed that nuclear IRF3 is transcriptionally active. Likewise, the lack of IP-10 induction suggested OSU may encode a mechanism to block activation of NF?B.
NF?B activation in OSU infected cells first was evaluated with the p50 TransAM ELISA, which measures phosphorylated p50 subunit binding to DNA. MA104 cells were infected with A5-16, NCDV, or OSU, and whole cell lysates were harvested six hours post infection (hpi). The amount of activated p50 was significantly higher in A5-16 and NCDV infected cell lysates compared to lysates from mock infected cells (Figure 2A and Figure S1A). By contrast, the amount of activated p50 in OSU infected cell lysates was not different from mock infected controls. The NF?B p50 subunit most commonly forms a p65-p50 heterodimer with transactivation activity . However, p50 also forms homodimers that act as repressors when bound to promoters because the p50 subunit lacks a transactivation domain . The ELISA did not detect elevated levels of p50 capable of binding DNA in OSU infected cells, indicating that infection did not induce formation of the activated p65-p50 heterodimer or the inhibitory p50 homodimer.
Given the previously defined role for NSP1 in IRF degradation, we asked whether NSP1 played a role in modulating the activity of NF?B. 293-TLR3 cells were co-transfected with pO-NSP1 or pN-NSP1, and a luciferase reporter plasmid that contained tandem repeats of ?B binding sites. The cells then were treated with polyI:C, and reporter expression was analyzed by luciferase assay (Figure 2B). Expression of OSU NSP1 resulted in ?20-fold inhibition of NF?B promoter-driven reporter gene expression relative to cells transfected with the empty vector. A five-fold inhibition of luciferase expression was observed in cells expressing NCDV NSP1, indicating some degree of NF?B inhibition by this strain. Previously, we showed that OSU NSP1 accumulates to higher levels than NCDV NSP1 in transfected 293 cells. Immunoblot analysis of cell lysates used for the luciferase reporter experiments showed that NCDV NSP1 and OSU NSP1 were expressed at equal levels (Figure S2), indicating the difference in fold-inhibition between NSP1 of these two strains is not due to differences in levels of expression. Taken together, these data suggested that a predominant mechanism of IFN antagonism in OSU infected cells was interference with activation of NF?B, and that OSU NSP1 alone could mediate this effect. Moderate inhibition of NF?B activation in NCDV infected cells and NCDV NSP1-expressing cells also was observed. However, data from the p50 DNA binding ELISA and reporter gene assay together suggest NCDV is less efficient than OSU in blocking activation of NF?B.
The fact that IRF3 is targeted for proteasome degradation by some rotavirus strains led us to test whether degradation of NF?B subunits was responsible for the block to NF?B activation. Whole cell lysates from mock infected and infected cells were collected every two hours for ten hours, and the abundance of p65 (Figure 3A) and p50 (data not shown) was analyzed by immunoblot. The levels of both p65 and p50 in cells infected with the three viruses were equal to the level detected in mock infected cells, indicating that degradation of these subunits was not induced by any of the virus strains tested.
Inhibition of NF?B reporter activation and stability of NF?B subunits in OSU and NCDV infected cells led us to test whether p65 was transcriptionally functional. Cells were mock infected or infected as before, and activated p65 in nuclear fractions was measured with the p65 TransAM ELISA. Consistent with the reporter assays, the amount of activated p65 in OSU and NCDV infected cells was significantly less than that in A5-16 infected cells (Figure 4A). The amount of nuclear p65 also was measured by immunoblot (Figure 4B). The results indicated that the highest amount of p65 was present in the A5-16 fractions, consistent with induction of NF?B dependent gene expression in A5-16 infected cells. In contrast, very little p65 was detected in fractions from OSU and NCDV infected cells. The cytoplasmic carryover in the fractions of all the samples shown by the presence of GAPDH is nearly identical, including the mock infected control. While these data do not quantitatively assess the amount of p65 that translocates to the nucleus compared to what remains in the cytoplasm, the relative amounts of p65 in each fraction can be compared, and clearly illustrate the significant difference between the amount of p65 present in A5-16 lysates and lysates from OSU and NCDV infected cells.
The lack of p65 activation and the low amounts of p65 in the nucleus of OSU and NCDV infected cells led us to further evaluate the subcellular localization by IF microscopy. MA104 cells were infected for six hours with A5-16, NCDV or OSU, and p65 was localized by staining with an anti-p65 antibody (Figure 3B). p65 was distributed in a diffuse pattern throughout the cytoplasm in mock infected cells as expected. In A5-16 and NCDV infected cells, nuclear staining of p65 was evident, indicating some degree of translocation occurred. p65 localization in OSU infected cells was distinct, as it was detected in the nucleus at very low levels and only in filament-like structures that were inconsistent with the typical distribution pattern displayed by p65 in transcriptionally active complexes. The vast majority of p65 in OSU infected cells was exclusively localized to cytoplasmic perinuclear structures that also were observed, but to a lesser extent in A5-16 and NCDV infected cells. These structures were reminiscent of viroplasms formed in rotavirus infected cells, where genome replication, packaging and particle assembly occur. Double staining with anti-p65 and an antibody to structural protein VP6, and analysis by confocal microscopy showed these two proteins co-localized in infected cells, suggesting p65 that does not translocate to the nucleus is associated with viroplasms (Figure S3A, Protocol S1). Co-immunopreciptation of viral proteins with p65 confirmed this association (Figure S3B). The observed filament structures in the nucleus resembled actin fibers formed in the nucleus of herpesvirus infected cells , but their origin was not further investigated in this study.
Phosphorylation of I?B? and subsequent ubiquitination and proteasome degradation is required for activation of NF?B. To assess the activation status of I?B?, lysates from cells infected with each of the three virus strains were prepared every two hours for ten hours, and I?B? was analyzed by immunoblot. I?B? was substantially degraded by six hpi in A5-16 infected cells (Figure 5A), but stable in the presence of MG132, confirming proteasome-dependent degradation (Figure S4). By contrast, I?B? was detected in lysates from NCDV and OSU infected cells through the ten hour time point. Although I?B? was present at each time point through the conclusion of the time course, analysis of band intensities by densitometry from three independent experiments indicated that I?B? was present in NCDV and OSU infected lysates at levels approximately 50% of the mock infected controls (Figure 5B). Therefore, some I?B degradation does occur, most likely prior to accumulation of levels of viral protein sufficient to block this activity.
I?B? is phosphorylated by the IKK complex on serine residues 32 and 36, resulting in recognition and ubiquitination by the SCF??TrCP E3 ubiquitin ligase complex ,. To distinguish between a block to phosphorylation of I?B? and a block to subsequent proteasome degradation, immunoblots were probed with an antibody that recognizes the phosphorylated form of I?B? (p-I?B?, Figure 5C). Phosphorylated I?B? was not detected at any time during the infection with A5-16 because this form is rapidly degraded. In OSU and NCDV infected cells, p-I?B? accumulated through ten hpi, with peak accumulation observed at 4?6 hpi. The presence of p-I?B? indicated that activity of the IKK complex was not disrupted by either of these viruses, and that proteasome-mediated degradation of I?B? is inhibited by both.
Degradation of I?B? is rapidly induced in cells treated with TNF?. To determine if I?B? was stable in cells when the stimulus was not virus infection, and to confirm that p-I?B? was stable, we tested whether TNF? induced I?B? degradation in infected cells. MA104 cells were mock infected or infected for eight hours, and then treated with TNF? for 15 minutes. Cell lysates then were probed with antibody to total I?B? or to p-I?B?. The results revealed that upon treatment with TNF?, I?B? was phosphorylated and stable in NCDV and OSU infected cells, but not in mock infected cells (Figure 5D). These data show that treatment with a strong inducer of NF?B does not overcome the virus infection-associated block in this signaling pathway, and further support the conclusion that I?B? degradation is actively inhibited in OSU and NCDV infected cells.
The SCF?-TrCP E3 ligase complex mediates proteasome-dependent degradation of several proteins with roles in regulating cell proliferation, including I?B?, NF?B subunits p100 and p105, cyclin dependent kinases, and ?-catenin, among others . SCF?-TrCP is a negative regulator of the Wnt/? catenin signaling pathway, and as such, expression of dominant negative mutants of ?-TrCP results in accumulation of ?-catenin . We reasoned that if SCF?-TrCP was nonfunctional in infected cells, ?-catenin, in addition to I?B?, would accumulate to a level higher than that in mock infected controls. The amount of ?-catenin in OSU infected cells at ten hours post infection was consistently higher than mock infected cells, suggesting activity of SCF?-TrCP was impaired (Figure S5).
To test the theory that SCF?-TrCP may not be functional in OSU and NCDV infected cells, 293 cells were transfected with a plasmid encoding a Flag-tagged ?-TrCP, and then infected with the three strains as in prior experiments. Immunoblots were probed with anti-Flag antibody to detect ?-TrCP, or NSP1 polyclonal antibody. In A5-16 infected cells, ?-TrCP was present in approximately the same amounts as the transfected, uninfected control (Figure 6A). ?-TrCP was not detected in either NCDV infected cells or OSU (input panel) infected cells. These data led us to suspect that ?-TrCP may be targeted to the proteasome in cells infected with these two strains. To address this question, cells were transfected with Flag-?-TrCP, and then infected in the presence of proteasome inhibitor MG132. Immunoblots were probed with anti-Flag or anti-NSP1 antibodies. The results showed that when proteasome activity is inhibited, ?-TrCP is stable in infected cells (Figure 6B). The fact that ?-TrCP was stable in cells infected with A5-16 in the absence of MG132, suggested that NSP1 played a role in this process.
NSP1-directed degradation of IRF3 requires an interaction between the two proteins. We tested whether NSP1 interacted with ?-TrCP. 293 cells were co-transfected with plasmids encoding NSP1 and Flag-?-TrCP in the presence of MG132, and co-immunoprecipitations were performed with anti-Flag antibody, followed by immunoblot with either anti-Flag or anti-myc antibody to detect NSP1. NSP1 of both OSU and NCDV co-immunoprecipitated with ?-TrCP when cells were treated with MG132 to protect ?-TrCP from degradation (Figure 7). We note that ?-TrCP is not detected in the input lanes even in the presence of MG132, in contrast to the data shown in Figure 6B. We believe this is a consequence of the experimental conditions, in that an eight hour treatment with MG132 is insufficient to allow ?-TrCP to accumulate to detectable levels when it is co-expressed with NSP1 for 40 hours prior to addition of the proteasome inhibitor. The immunoprecipitation reactions in this case effectively concentrate the amount of ?-TrCP remaining so that it is detected in complex with NSP1. In addition, there is an obvious difference in the amount of OSU NSP1 present in cells that were co-transfected with ?-TrCP compared to those transfected with the NSP1 plasmid alone (Figure 7, pO-NSP1 input lanes), such that NSP1 appears stabilized in the presence of ?-TrCP. We have observed an increase in the levels of expression of both NSP1 and EYFP when this construct is co-transfected with the ?-TrCP plasmid. The reasons for the increase are not known, but as shown by the data in Figure 6, the presence of ?-TrCP has no effect on the levels of NSP1 synthesized in native virus infected cells. The interaction between NSP1 and ?-TrCP was confirmed to occur in OSU infected cells by co-immunoprecipitation of NSP1 with ?-TrCP from Flag-?-TrCP expressing cells (see Figure 6A, IP panel).
It is clear that viruses encode proteins that down-regulate cellular immune responses, yet the strategies are disparate, and include interference with both innate and adaptive pathways. We report a novel immune evasion mechanism in which a viral nonstructural protein targets the substrate recognition component of a multisubunit cellular E3 ligase for proteasome degradation. At least one functional consequence of ?-TrCP degradation relevant to induction of the innate immune response is inhibition of NF?B activation and IFN?/? expression. However, SCF?-TrCP also regulates stability of proteins involved in control of cell proliferation including ?-catenin, Emi1, and cyclin dependent kinases, among many others . As such, over-expression of ?-TrCP and consequent constitutive activation of NF?B has been reported in several tumor cell lines ,,,. It stands to reason then, that in the context of viral infection, the effects of the absence of ?-TrCP on the proliferative state of the cell also may play a role in modulating virus replication. Blocking NF?B activation in response to cell stress will result in amplification of a pro-apoptotic response. Several studies have shown that rotavirus infection induces apoptosis both in vitro and in vivo, and mechanisms including most recently, induction by the intrinsic pathway, have been reported ,,. Together, the data suggest that inducing apoptosis may be advantageous for rotavirus replication and spread, and it remains to be determined whether blocking apoptosis will affect virus spread or progeny production.
While targeted degradation of ?-TrCP by NSP1 is unique, viral manipulation of the ubiquitin-proteasome system is not . Some viral proteins modulate the ubiquitin-proteasome system by redirecting cellular E3 ligases to alternative substrates or directly interfering with their function. For example, V proteins of some viruses in the Paramyxoviridae target STAT1 and/or STAT2 for proteasome degradation, thus preventing assembly of ISGF3 ,,. IRF7 is required for a maximal IFN response and is a substrate for the Kaposi's sarcoma herpesvirus (KSHV) RTA ligase . Herpes simplex virus protein ICP0 has been well characterized, and induces proteasome-dependent degradation of the stress-related kinase DNA-PK  and promyelocytic leukemia protein ,. Viral infectivity factor (VIF) encoded in the HIV genome forms a ligase complex through interactions with the RING domain-containing protein Rbx1/Roc1, and recruits APOBEC3G as a substrate for ubiquitination, thus functioning as an F-box protein surrogate in cellular complexes .
Another HIV protein that manipulates the ubiquitin-dependent proteasome system and is particularly relevant to the work reported here is Vpu, most noted for its role in directing degradation of CD4 . Vpu binds CD4 and ?-TrCP, resulting in polyubiquitination of CD4 and proteasome degradation, but Vpu itself is not degraded through this interaction . It has been suggested that Vpu blocks NF?B activation in infected cells by acting as a competitive inhibitor for ?-TrCP binding, and consequently stabilizes I?B . NSP1-dependent proteasome-mediated degradation of ?-TrCP reveals a new mechanism for interfering with the function of this protein. It is now evident that major players in immune response signaling networks are targeted by viruses in several families, and therefore, consideration of ?-TrCP as another important target of IFN antagonism by multiple viruses seems warranted.
The conserved N-terminal cysteine-histidine rich region of NSP1 does not conform to standard RING domain signatures. However, mutational analysis has shown that cysteine and histidine residues in this region are required to direct IRF3 degradation in transfected cells . Direct evidence of intrinsic E3 ligase activity of NSP1 has not yet been reported, and in this context, it is appropriate to consider the mechanism by which NSP1 ?hijacks? the cellular ubiquitination machinery and directs proteasome degradation of selected substrates. RING domain-containing E3 ligases are either unimolecular or multisubunit, and viral E3 ligases exist in both categories . Unimolecular E3s recruit the cognate E2 through a RING domain, and the substrate through protein-protein interactions in a separate domain of the molecule. Single subunit E3s include cellular proteins c-Cbl , Mdm2 , and XIAP , and viral proteins RTA and ICP0 , all of which are relatively large proteins of >450 amino acids. In multisubunit ligases such as SCF?-TrCP, the RING domain protein Rbx1/Roc1 is ?100 amino acids and the substrate recognition component is a separate protein in the complex. NSP1 could assemble in SCF complexes, thus functioning as the substrate recognition component and RING finger protein of a multisubunit E3. The molecular weight of NSP1 (?490 amino acids) and predicted structure is most consistent with single subunit E3s, and we recently reported that NSP1 regulates its own stability in a proteasome-dependent manner . This auto-regulatory capability is characteristic of unimolecular cellular and viral E3s that have experimentally defined intrinsic ligase activity ,. A refined definition of the mechanism by which NSP1 functions in the ubiquitin-dependent proteasome pathway requires study of additional cellular interaction partners, including those specifically associated with ubiquitin ligase complexes. Likewise, the motifs in cellular proteins that dictate their recognition as NSP1 substrates are not known, and determining the range of activity of NSP1 will be important to decipher.
Since we had observed that IRF3 was activated in OSU infected cells but IFN? transcription still was inhibited, we expected an alternative mechanism was operational and independent of IRF3. The discovery that ?-TrCP was degraded in NCDV infected cells as well was unexpected, but not wholly surprising, because redundancy in mechanisms of viral interference with IFN signaling is well documented. NF?B activation was inhibited in NCDV infected cells, but the magnitude was much less than that observed in OSU infections. Therefore, IRF3 degradation in NCDV infected cells may be the dominant and most efficient mechanism of NSP1-mediated IFN antagonism for this strain, and perhaps other strains known to target IRF3. In contrast, OSU NSP1 does not strongly bind IRF3 in these cells lines, and inhibition of NF?B activity by degradation of ?-TrCP is dominant. Substrate specificity of NSP1 thus may define the prominent mechanism of IFN antagonism in different rotavirus strains.
The results of these studies also suggest rotaviruses utilize more than one mechanism to down-regulate NF?B-dependent gene expression that is independent of NSP1. There is similarity in the localization of p65 to viroplasms in cells infected with each virus, including A5-16 which does not encode NSP1, the obvious difference being that nuclear accumulation of transcriptionally active p65 in OSU infected cells was nearly completely blocked. This observation suggests OSU is more efficient at sequestering p65 in the cytoplasm and by extension, inhibiting NF?B activation, than NCDV and A5-16. Sequestration of an NF?B subunit in viroplasms and interactions with viral structural proteins is a novel observation. We have shown that p65 co-immunoprecipitates with at least three rotavirus proteins, and it will be of interest to determine the role of these proteins in the altered distribution of p65. It is possible that the degree of p65 sequestration depends on strain specific differences in kinetics or efficiency of viroplasm formation in infected cells.
NF?B-dependent cytokine induction and microarray data have shown increased expression of NF?B-regulated genes during rotavirus infection ,. Our data generally are not in conflict with these results. We observe moderate degradation of I?B? in both OSU and NCDV infected cells at early times post-infection, and it is plausible that some NF?B-dependent gene expression is induced. This makes sense given the time-lapse between activation of signal transduction pathways and accumulation of NSP1 in the cell. In this context, viral interference with these pathways functions to down-regulate the response instead of blocking its initial induction. Other rotaviruses reported so far to activate NF?B include among others, simian and rhesus strains that target IRF3 for degradation. Although we have not determined whether NF?B is activated in cells infected with these strains, we predict activity similar to NCDV. Continued analysis of the ways multiple rotavirus strains modulate the NF?B pathway will test this prediction.
Use of viruses that are unable to block IFN responses is becoming an attractive approach to development of attenuated virus vaccines ,,,,,. Generation of rotavirus vaccines containing strains with mutations within NSP1 may result in additional vaccine formulations that consist of attenuated virus isolated from homologous hosts. In this context, careful analysis of the functions of NSP1 in regulation of innate immune responses will be important for future studies.
MA104 cells were grown in M199 media (Mediatech) supplemented with 5% FBS (Atlanta Biologicals). HEK293 cells were grown in RPMI 1640 media (Mediatech) supplemented with 10% FBS, 10 mM HEPES, 1? nonessential amino acids, 2 mM L-glutamine, and 1 mM sodium pyruvate. 293-TLR3 cells (kindly provided by Dr G. Sen, Cleveland Clinic, Cleveland, OH), were grown in the same conditions as 293 cells, except that the media was supplemented with 400 ?g/mL of G418.
Isolation and characterization of rotavirus strains A5-16, NCDV, and OSU has been described ,,,. To prepare virus stocks, MA104 cells were infected at a multiplicity of infection (MOI) of 0.05, and harvested when ?95% cytopathic effect was observed. Culture media was clarified of cell debris by centrifugation at 2000?g for 10 minutes, and the virus in the supernatant was concentrated by centrifugation at 26,000 rpm in an SW28 rotor (Beckman) for two hours at 4?C. Virus pellets were suspended in serum-free M199, and stored in aliquots at ?80?C. Virus titers were determined by standard plaque assay.
Construction of expression plasmids encoding OSU NSP1 (pO-NSP1) and NCDV NSP1 (pN-NSP1) has been described . A myc epitope tag is fused to the NSP1 coding sequence of both for detection by immunoblot.
MA104 cells were infected with trypsin-activated virus at an MOI of three pfu/cell in serum-free M199. Eight hours post-infection (hpi), total cell RNA was extracted using TRIzol reagent (Invitrogen). RNA was treated with ten units of DNAse for 30 minutes at 37?C, and then extracted with phenol/chloroform. Reverse transcription reactions were performed with random hexamers (Promega) and Superscript II reverse transcriptase (Invitrogen), incubated for 50 minutes at 42?C. PCR reactions were performed with Taq polymerase (Promega). Gene-specific primers included: IFN? (forward [gene: 5? - CTC CTC CAA ATT GCT CTC CTG ? 3?]; reverse [gene: 5? ? GCA AAC TGC TCA CGA ATT TTC C ? 3?]), ISG56 (forward [gene: 5? ? AAC ACC TGA AAG GCC AGA ATG AGG-3?]; reverse [gene: 5? ? AAG ACA GAA GTG GGT GTT TCC TGC-3?]), IP-10 (forward [gene: 5? ? CTG CGA TTC TGA TTT GCT GCC ? 3?]; reverse [gene: 5? ? GGA GAT CTT TTA GAC ATT TCC TTG CTA ACT GC ? 3?]), and ?-actin (forward [gene: 5? ? CAT GTT TGA GAC CTT CAA CAC ? 3?]; reverse [gene: 5? ? CAT CTC CTG CTC GAA GTC TAG ? 3?]).
293-TLR3 cells were transfected using TransIT-293 Transfection Reagent (Mirus) according to the manufacturer's instructions. The luciferase control plasmid phRL-CMV was purchased from Promega. IFN?-Luc was kindly provided by Dr J. Hiscott, McGill University, Montreal, Quebec, CA, and pNF?B-Luc Cis Reporter Plasmid was purchased from Stratagene. Forty hours post-transfection, polyI:C (GE Healthcare) was added to the media at final concentration of 100 ?g/mL. Cell lysates were harvested eight hours post-treatment and reporter activity was measured using the Dual Luciferase Assay (Promega) and a Lumat LB 9507 luminometer (EG&G Berthold). Each transfection was performed in triplicate in two independent experiments.
NF?B subunit p50 was measured by the p50 TransAM ELISA (Active Motif). Whole cell extracts were prepared six hpi in Lysis Buffer AM1. Protein concentration was determined with the RC DC Protein Assay (Bio-Rad Laboratories) and 20 ?g of extract were used in a TransAM p50 Activation Assay (Active Motif). Specificity controls provided in both the p50 and p65 assays are shown in Figure S1. Three independent experiments were performed and p-values were determined by Student's unpaired t-test.
Nuclear p65 was analyzed with the p65 TransAM ELISA. Nuclear and cytoplasmic fractions were prepared six hpi with the nuclear extract kit following the manufacturer's instructions (Active Motif). Protein concentration was determined with the RC DC protein assay and five ?g of nuclear extract were used in the assay (Active Motif). Three independent experiments were performed and p-values were determined by Student's unpaired t-test.
Cell lysates were harvested at the indicated times post-infection in RIPA buffer (150 mM NaCl, 1% sodium deoxycholate, 1% Triton X-100, 0.1% SDS, 10 mM Tris-HCl pH 7.2). Immunoblots were performed as previously described . Primary antibodies against the following proteins were used: p65 (Rockland), I?B? (Cell Signaling), I?B? phosphorylated on serine 32 (Cell Signaling), GAPDH (Ambion), anti-FLAG (Sigma), anti-NCDV NSP1 and anti-OSU NSP1. Rabbit polyclonal antiserum to OSU NSP1 generated against a synthetic peptide near the C terminus of the protein and was made by Open Bioscience, Inc.
For immunoprecipitation from infected cell lysates, HEK293 cells were mock transfected or transfected with pCMV-Flag-?-TrCP2 (kindly provided by Dr. W. Harper, Department of Pathology, Harvard Medical School, Boston, MA). Twenty hours post-transfection, the media was changed to serum-free RPMI 1640 and the cells were infected with three pfu/cell of OSU or NCDV. Cells were harvested eight hpi in 500 ?L FLAG immunoprecipitation lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA) supplemented with protease inhibitor cocktail (Roche Diagnostics). Lysates were passed through a 30 gauge needle five times and subsequently pre-cleared by centrifugation for 10 minutes at 10,000?g. Ten percent of each sample was set aside as input, and the FLAG-tagged ??TrCP was immunoprecipitated from the remaining lysate using anti-FLAG M2-Agarose Affinity Gel (Sigma) according to the manufacturer's recommendations. The input and eluted samples were used in immunoblot analysis using antibodies against FLAG (Sigma), and OSU NSP1 or NCDV NSP1. Immunoprecipitations from cells co-transfected with pFlag-?-TrCP and pN- or pO-NSP1 were performed the same way, except that MG132 was added to the media 40 hours post-transfection, followed by an additional eight hour incubation.
MA104 cells were grown in four-well chamber slides (BD Falcon) and infected with three pfu/cell using rotavirus stocks that were activated with 10 ?g/mL Worthington trypsin for 30 minutes at 37?C. Six hpi, the cells were fixed with paraformaldehyde (2% w/v in PBS) for 10 minutes at room temperature and then permeabilized with methanol for 10 minutes at ?20?C. The samples were incubated in blocking solution (PBS supplemented with 5% v/v horse serum and 5% v/v goat serum) overnight at 4?C. Primary antibody diluted in blocking serum was added and cells were incubated for one hour at room temperature, followed by three rinses with PBS. The primary antibodies were mouse anti-IRF3 (Santa Cruz Biotechnology) or rabbit anti-p65 (Rockland). The cells were then stained the appropriate Alexa Fluor-conjugated goat secondary antibodies (Invitrogen) and mounted in ProLong Gold (Invitrogen) under a glass cover slip. Cells stained for IRF3 were viewed on an AxioImager.A1 microscope (Zeiss) using a 40? (0.75 NA) objective lens. The images were obtained using an AxioCam MRc5 camera (Zeiss) and analyzed with the Axiovision version 4.6.3 (Zeiss) software package. Exposure parameters were equal for images of each sample. Cells stained for p65 were viewed on an LSM 510 Meta confocal microscope (Zeiss) using a 63? (1.40 NA) objective lens. Excitation of Alexa Fluor 594-conjugated secondary antibody was achieved using a 543 nm helium-neon laser. The pinhole was set to 1 Airy unit. Images were obtained with each line being scanned eight times to increase the signal-to-noise ratio. The images were analyzed with the LSM Image Browser (Zeiss).
Specificity of p50 and p65 binding in TransAM assays. MA104 cells were infected with A5-16, NCDV, or OSU as described in the text. Lysates were prepared six hours post infection and subjected to the (A) p50 or (B) p65 binding assay. Competitor oligonucleotides are wildtype (w) or mutant (m).
(3.00 MB TIF)
Click here for additional data file (ppat.1000280.s001.png)
Immunoblot analysis of lysates used in luciferase reporter assays. Cell lysates used in the NF?B and IFN? reporter luciferase assays (Figure 2B and Figure 1C, respectively) were analyzed by immunoblot with anti-myc antibody to detect myc-tagged NSP1. The asterisk indicates a protein that cross-reacts with the myc antibody. The blots were probed for GAPDH as a loading control.
(0.37 MB TIF)
Click here for additional data file (ppat.1000280.s002.png)
p65 co-localizes with VP6 and NSP2 in viroplasms. (A) The cellular localization of p65, VP6, and NSP2 in MA104 cells infected with three pfu/cell of the indicated virus strain was determined by confocal microscopy (63?, NA 1.40) at six hpi. The zoom function was used to allow for analysis of individual cells. (B) Interactions between p65 and rotavirus proteins were determined by co-immunoprecipitation. Rotavirus proteins were radiolabeled for six hours in MA104 cells infected with ten pfu/cell of the indicated virus strain (details in Materials and Methods). Cell lysates were prepared and 10% of each sample was set aside as input control. The remaining lysate was divided equally for immunoprecipitation with anti-p65 antibody. Input controls and immunoprecipitated samples were separated by SDS-PAGE, and radiolabeled proteins were detected by autoradiography.
(2.16 MB TIF)
Click here for additional data file (ppat.1000280.s003.png)
I?B? degradation is proteasome dependent. MA104 cells were infected with A5-16 in the absence or presence of 10 ?M MG132. Immunoblots were probed with anti-I?B? and anti-GAPDH.
(3.00 MB TIF)
Click here for additional data file (ppat.1000280.s004.png)
?-catenin is stabilized in OSU infected cells. Cell lysates were collected ten hpi from 293 cells infected with three pfu/cell of the indicated virus strain. The abundance of ?-catenin was determined by immunoblot and densitometry normalized to GAPDH. The level of ?-catenin in OSU infected cells was ?2?4 fold higher than in mock infected or A5-16 infected cells.
(0.72 MB TIF)
Click here for additional data file (ppat.1000280.s005.png)
(0.04 MB DOC)
Click here for additional data file (ppat.1000280.s006.doc)
The authors have declared that no competing interests exist.
This study has been funded by USDA/NRICGP 02657, DoD contract W9113M-04-1-0010, PHS grant P20 RR020185, and the Montana Agriculture Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
We extend appreciation to Drs. G. Sen, J. Hiscott and J. Harper for generously providing cell lines and plasmids, to Dr. K. Taniguchi (Fujita Health University School of Medicine, Aichi, Japan), for providing us with the A5-16 rotavirus strain, and to Dr. M. Estes for the NSP2 antibody. We also thank Dana Kreitel for technical support.
|1.||Randall RE,Goodbourn S. 2008;Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures.J Gen Virol 89:1–47. [pmid: 18089727]|
|2.||Borden EC,Sen GC,Uze G,Silverman RH,Ransohoff RM,et al. 2007;Interferons at age 50: past, current and future impact on biomedicine.Nat Rev Drug Discov 6:975–990. [pmid: 18049472]|
|3.||Seth RB,Sun L,Ea CK,Chen ZJ. 2005;Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3.Cell 122:669–682. [pmid: 16125763]|
|4.||Lin R,Lacoste J,Nakhaei P,Sun Q,Yang L,et al. 2006;Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage.J Virol 80:6072–6083. [pmid: 16731946]|
|5.||Meylan E,Curran J,Hofmann K,Moradpour D,Binder M,et al. 2005;Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus.Nature 437:1167–1172. [pmid: 16177806]|
|6.||Lin R,Heylbroeck C,Pitha PM,Hiscott J. 1998;Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation.Mol Cell Biol 18:2986–2996. [pmid: 9566918]|
|7.||Schafer SL,Lin R,Moore PA,Hiscott J,Pitha PM. 1998;Regulation of type I interferon gene expression by interferon regulatory factor-3.J Biol Chem 273:2714–2720. [pmid: 9446577]|
|8.||Wathelet MG,Lin CH,Parekh BS,Ronco LV,Howley PM,et al. 1998;Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo.Mol Cell 1:507–518. [pmid: 9660935]|
|9.||Haller O,Kochs G,Weber F. 2006;The interferon response circuit: induction and suppression by pathogenic viruses.Virology 344:119–130. [pmid: 16364743]|
|10.||Fitzgerald KA,McWhirter SM,Faia KL,Rowe DC,Latz E,et al. 2003;IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway.Nat Immunol 4:491–496. [pmid: 12692549]|
|11.||Li K,Foy E,Ferreon JC,Nakamura M,Ferreon AC,et al. 2005;Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.Proc Natl Acad Sci U S A 102:2992–2997. [pmid: 15710891]|
|12.||Barro M,Patton JT. 2005;Rotavirus nonstructural protein 1 subverts innate immune response by inducing degradation of IFN regulatory factor 3.Proc Natl Acad Sci U S A 102:4114–4119. [pmid: 15741273]|
|13.||Barro M,Patton JT. 2007;Rotavirus NSP1 inhibits expression of type I interferon by antagonizing the function of interferon regulatory factors IRF3, IRF5, and IRF7.J Virol 81:4473–4481. [pmid: 17301153]|
|14.||Graff JW,Ewen J,Ettayebi K,Hardy ME. 2007;Zinc-binding domain of rotavirus NSP1 is required for proteasome-dependent degradation of IRF3 and autoregulatory NSP1 stability.J Gen Virol 88:613–620. [pmid: 17251580]|
|15.||Sizemore N,Agarwal A,Das K,Lerner N,Sulak M,et al. 2004;Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes.Proc Natl Acad Sci U S A 101:7994–7998. [pmid: 15148408]|
|16.||Peters KL,Smith HL,Stark GR,Sen GC. 2002;IRF-3-dependent, NFkappa B- and JNK-independent activation of the 561 and IFN-beta genes in response to double-stranded RNA.Proc Natl Acad Sci U S A 99:6322–6327. [pmid: 11972054]|
|17.||Hayden MS,Ghosh S. 2008;Shared principles in NF-kappaB signaling.Cell 132:344–362. [pmid: 18267068]|
|18.||Kroll M,Margottin F,Kohl A,Renard P,Durand H,et al. 1999;Inducible degradation of IkappaBalpha by the proteasome requires interaction with the F-box protein h-betaTrCP.J Biol Chem 274:7941–7945. [pmid: 10075690]|
|19.||Hiscott J,Nguyen TL,Arguello M,Nakhaei P,Paz S. 2006;Manipulation of the nuclear factor-kappaB pathway and the innate immune response by viruses.Oncogene 25:6844–6867. [pmid: 17072332]|
|20.||Glass RI,Parashar UD,Bresee JS,Turcios R,Fischer TK,et al. 2006;Rotavirus vaccines: current prospects and future challenges.Lancet 368:323–332. [pmid: 16860702]|
|21.||Hua J,Mansell EA,Patton JT. 1993;Comparative analysis of the rotavirus NS53 gene: conservation of basic and cysteine-rich regions in the protein and possible stem-loop structures in the RNA.Virology 196:372–378. [pmid: 8395125]|
|22.||Pickart CM. 2001;Mechanisms underlying ubiquitination.Annu Rev Biochem 70:503–533. [pmid: 11395416]|
|23.||Barlow PN,Luisi B,Milner A,Elliott M,Everett R. 1994;Structure of the C3HC4 domain by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger.J Mol Biol 237:201–211. [pmid: 8126734]|
|24.||Aravind L,Iyer LM,Koonin EV. 2003;Scores of RINGS but no PHDs in ubiquitin signaling.Cell Cycle 2:123–126. [pmid: 12695663]|
|25.||Chen M,Gerlier D. 2006;Viral hijacking of cellular ubiquitination pathways as an anti-innate immunity strategy.Viral Immunol 19:349–362. [pmid: 16987055]|
|26.||Tan P,Fuchs SY,Chen A,Wu K,Gomez C,et al. 1999;Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of I kappa B alpha.Mol Cell 3:527–533. [pmid: 10230406]|
|27.||Shirane M,Hatakeyama S,Hattori K,Nakayama K. 1999;Common pathway for the ubiquitination of IkappaBalpha, IkappaBbeta, and IkappaBepsilon mediated by the F-box protein FWD1.J Biol Chem 274:28169–28174. [pmid: 10497169]|
|28.||Taniguchi K,Kojima K,Urasawa S. 1996;Nondefective rotavirus mutants with an NSP1 gene which has a deletion of 500 nucleotides, including a cysteine-rich zinc finger motif-encoding region (nucleotides 156 to 248), or which has a nonsense codon at nucleotides 153?155.J Virol 70:4125–4130. [pmid: 8648754]|
|29.||Graff JW,Mitzel DN,Weisend CM,Flenniken ML,Hardy ME. 2002;Interferon regulatory factor 3 is a cellular partner of rotavirus NSP1.J Virol 76:9545–9550. [pmid: 12186937]|
|30.||Sarkar SN,Peters KL,Elco CP,Sakamoto S,Pal S,et al. 2004;Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling.Nat Struct Mol Biol 11:1060–1067. [pmid: 15502848]|
|31.||Grandvaux N,Servant MJ,tenOever B,Sen GC,Balachandran S,et al. 2002;Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes.J Virol 76:5532–5539. [pmid: 11991981]|
|32.||Plaksin D,Baeuerle PA,Eisenbach L. 1993;KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.J Exp Med 177:1651–1662. [pmid: 8496683]|
|33.||Feierbach B,Piccinotti S,Bisher M,Denk W,Enquist LW. 2006;Alpha-herpesvirus infection induces the formation of nuclear actin filaments.PLoS Pathog 2:e85. doi:10.1371/journal.ppat.0020085 [pmid: 16933992]|
|34.||Brown K,Gerstberger S,Carlson L,Franzoso G,Siebenlist U. 1995;Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation.Science 267:1485–1488. [pmid: 7878466]|
|35.||Frescas D,Pagano M. 2008;Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer.Nat Rev Cancer 8:438–449. [pmid: 18500245]|
|36.||Latres E,Chiaur DS,Pagano M. 1999;The human F box protein beta-Trcp associates with the Cul1/Skp1 complex and regulates the stability of beta-catenin.Oncogene 18:849–854. [pmid: 10023660]|
|37.||Ougolkov A,Zhang B,Yamashita K,Bilim V,Mai M,et al. 2004;Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer.J Natl Cancer Inst 96:1161–1170. [pmid: 15292388]|
|38.||Muerkoster S,Arlt A,Sipos B,Witt M,Grossmann M,et al. 2005;Increased expression of the E3-ubiquitin ligase receptor subunit betaTRCP1 relates to constitutive nuclear factor-kappaB activation and chemoresistance in pancreatic carcinoma cells.Cancer Res 65:1316–1324. [pmid: 15735017]|
|39.||Koch A,Waha A,Hartmann W,Hrychyk A,Schuller U,et al. 2005;Elevated expression of Wnt antagonists is a common event in hepatoblastomas.Clin Cancer Res 11:4295–4304. [pmid: 15958610]|
|40.||Spiegelman VS,Tang W,Chan AM,Igarashi M,Aaronson SA,et al. 2002;Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling.J Biol Chem 277:36624–36630. [pmid: 12151397]|
|41.||Sato A,Iizuka M,Nakagomi O,Suzuki M,Horie Y,et al. 2006;Rotavirus double-stranded RNA induces apoptosis and diminishes wound repair in rat intestinal epithelial cells.J Gastroenterol Hepatol 21:521–530. [pmid: 16638093]|
|42.||Martin-Latil S,Mousson L,Autret A,Colbere-Garapin F,Blondel B. 2007;Bax is activated during rotavirus-induced apoptosis through the mitochondrial pathway.J Virol 81:4457–4464. [pmid: 17301139]|
|43.||Superti F,Ammendolia MG,Tinari A,Bucci B,Giammarioli AM,et al. 1996;Induction of apoptosis in HT-29 cells infected with SA-11 rotavirus.J Med Virol 50:325–334. [pmid: 8950690]|
|44.||Didcock L,Young DF,Goodbourn S,Randall RE. 1999;The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation.J Virol 73:9928–9933. [pmid: 10559305]|
|45.||Young DF,Didcock L,Goodbourn S,Randall RE. 2000;Paramyxoviridae use distinct virus-specific mechanisms to circumvent the interferon response.Virology 269:383–390. [pmid: 10753717]|
|46.||Parisien JP,Lau JF,Rodriguez JJ,Sullivan BM,Moscona A,et al. 2001;The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2.Virology 283:230–239. [pmid: 11336548]|
|47.||Yu Y,Wang SE,Hayward GS. 2005;The KSHV immediate-early transcription factor RTA encodes ubiquitin E3 ligase activity that targets IRF7 for proteosome-mediated degradation.Immunity 22:59–70. [pmid: 15664159]|
|48.||Parkinson J,Lees-Miller SP,Everett RD. 1999;Herpes simplex virus type 1 immediate-early protein vmw110 induces the proteasome-dependent degradation of the catalytic subunit of DNA-dependent protein kinase.J Virol 73:650–657. [pmid: 9847370]|
|49.||Boutell C,Orr A,Everett RD. 2003;PML residue lysine 160 is required for the degradation of PML induced by herpes simplex virus type 1 regulatory protein ICP0.J Virol 77:8686–8694. [pmid: 12885887]|
|50.||Chelbi-Alix MK,de The H. 1999;Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins.Oncogene 18:935–941. [pmid: 10023669]|
|51.||Yu X,Yu Y,Liu B,Luo K,Kong W,et al. 2003;Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.Science 302:1056–1060. [pmid: 14564014]|
|52.||Margottin F,Bour SP,Durand H,Selig L,Benichou S,et al. 1998;A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif.Mol Cell 1:565–574. [pmid: 9660940]|
|53.||Joazeiro CA,Wing SS,Huang H,Leverson JD,Hunter T,et al. 1999;The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.Science 286:309–312. [pmid: 10514377]|
|54.||Fang S,Jensen JP,Ludwig RL,Vousden KH,Weissman AM. 2000;Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53.J Biol Chem 275:8945–8951. [pmid: 10722742]|
|55.||Yang Y,Fang S,Jensen JP,Weissman AM,Ashwell JD. 2000;Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.Science 288:874–877. [pmid: 10797013]|
|56.||Hagglund R,Roizman B. 2004;Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.J Virol 78:2169–2178. [pmid: 14963113]|
|57.||Casola A,Garofalo RP,Crawford SE,Estes MK,Mercurio F,et al. 2002;Interleukin-8 gene regulation in intestinal epithelial cells infected with rotavirus: role of viral-induced IkappaB kinase activation.Virology 298:8–19. [pmid: 12093168]|
|58.||Cuadras MA,Feigelstock DA,An S,Greenberg HB. 2002;Gene expression pattern in Caco-2 cells following rotavirus infection.J Virol 76:4467–4482. [pmid: 11932413]|
|59.||Talon J,Salvatore M,O'Neill RE,Nakaya Y,Zheng H,et al. 2000;Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.Proc Natl Acad Sci U S A 97:4309–4314. [pmid: 10725408]|
|60.||Ferko B,Stasakova J,Romanova J,Kittel C,Sereinig S,et al. 2004;Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.J Virol 78:13037–13045. [pmid: 15542655]|
|61.||Valarcher JF,Furze J,Wyld S,Cook R,Conzelmann KK,et al. 2003;Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins.J Virol 77:8426–8439. [pmid: 12857912]|
|62.||Hartman AL,Dover JE,Towner JS,Nichol ST. 2006;Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.J Virol 80:6430–6440. [pmid: 16775331]|
|63.||Liu WJ,Wang XJ,Clark DC,Lobigs M,Hall RA,et al. 2006;A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice.J Virol 80:2396–2404. [pmid: 16474146]|
|64.||Pereira HG,Azeredo RS,Fialho AM,Vidal MN. 1984;Genomic heterogeneity of simian rotavirus SA11.J Gen Virol 65(Pt 4):815–818. [pmid: 6323623]|
|65.||Theil KW,Bohl EH,Agnes AG. 1977;Cell culture propagation of porcine rotavirus (reovirus-like agent).Am J Vet Res 38:1765–1768. [pmid: 201198]|
|66.||Woode GN,Kelso NE,Simpson TF,Gaul SK,Evans LE,et al. 1983;Antigenic relationships among some bovine rotaviruses: serum neutralization and cross-protection in gnotobiotic calves.J Clin Microbiol 18:358–364. [pmid: 6311873]|
Previous Document: Selective transmission of R5 HIV-1 over X4 HIV-1 at the dendritic cell-T cell infectious synapse is ...
Next Document: Estimation of transmission parameters of H5N1 avian influenza virus in chickens.